My mother, who was once the primary caretaker of her husband and three kids, who worked as a substitute teacher and part time editor of the Harvard Business Review, who threw amazing parties and volunteered at the temple and ran a gourmet catering business in her spare time, has Alzheimer's Disease, just as her mother and brother had it before her.
Biogen Inc.'s recent revelation of promising early data from an experimental Alzheimer's treatment is something of a breakthrough: it's the first time that we have seen positive human data about a new Alzheimer's drug that can both reduce the presence of amyloid plaques in the brain and improve cognitive function.
An Oscar for "Still Alice" is shining the brightest light yet on Alzheimer's, but light isn't enough anymore. Attention isn't enough. It's time to get serious. Alzheimer's is exerting a powerful impact on American families -- on our health, our finances, and our futures. And women are disproportionately impacted.